Nutraceutical CDMO Market Size, Share & Growth Trends to 2030: Rising Demand for Supplements & Wellness Focus Driving 8% CAGR

The nutraceutical CDMO is expected to grow at a CAGR 8% over the forecast period. The key drivers of this growth are the increasing demand for nutraceutical supplements, technological advancements, the shift towards plant-based and Ayurvedic products, expanding nutraceutical application, growing outsourcing trends, adoption of sedentary life style and rising aging population and increased consumer focus on wellness.

A nutraceutical CDMO is a company which provides outsourced services in the areas of formulation, manufacturing and packaging of nutraceutical supplements on behalf of health supplement and brand owners.

Browse market trends, size, share and growth report - request a sample copy: https://meditechinsights.com/nutraceutical-cdmo-market/request-sample/

Nutraceutical CDMOs are growing due to the demand for these products.

Nutraceutical products are a broad range of substances and foods that provide medical or health benefits above and beyond basic nutrition. They aim to support disease prevention and therapy. The demand for these products is increasing as dietary habits change, due to increased consumer awareness, the rising prevalence of noncommunicable diseases and rising healthcare costs. Multivitamin consumption is also expected to increase as consumers place greater emphasis on immune system support. This trend gained momentum during the COVID-19 epidemic and is likely continue in the future. Nutraceutical companies are increasingly partnering up with CDMOs to meet the changing consumer demands. They do this for cost-effective large-scale production, advanced R&D capability, and regulatory compliance. CDMOs are able to provide expertise in quality assurance and labeling. They also conduct clinical trials and adhere to global and FDA regulations. This ensures that brands can deliver products of high-quality and compliance. The rapid expansion of direct-to-consumer brands and e-commerce has accelerated the demand for private-label solutions and turnkey manufacturing. CDMOs are vital to the nutraceutical sector's rapid growth. They help brands scale efficiently, create innovative formulations and cater to consumer demand for health- and wellness-related solutions.

The nutraceutical industry is experiencing a surge in outsourcing.

Nutraceuticals, such as probiotics and dietary components like folic acids and fish oils, offer significant health benefits. These include supporting biological processes to prevent chronic diseases, promote healthy aging and maintain the body's function and structure. Many nutraceutical firms are turning to CDMOs that specialize in fine chemicals as they look to capitalize on the growing market. CDMOs offer end-to-end services, including R&D and formulation, raw materials sourcing, production and packaging, labeling and packaging. This allows companies to focus their efforts on marketing, branding and distribution, while outsourcing manufacturing complexity. This approach helps streamline manufacturing, reduce costs, improve product quality, and ensure compliance with industry regulations. CDMOs can help nutraceutical firms grow by reducing capital investment, providing regulatory compliance expertise, enhancing manufacturing capabilities, and facilitating development cycles.

Competitive Landscape Analysis

The global nutraceutical CDMO market is marked by the presence of established and emerging market players such as Catalent Inc.; Lonza; NutraScience Labs; Robinson Pharma, Inc.; Health Wright Products, Inc.; INPHARMA S.p.A.; Aenova Group; NutraPakUSA; SFI Health; Eurofins; WuXi AppTec; and Charles River Laboratories; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and investments.

Explore the latest trends and deep insights in just one click: https://meditechinsights.com/nutraceutical-cdmo-market/

Market Segmentation

This report by Medi-Tech Insights provides the size of the global nutraceutical CDMO market at the regional- and country-level from 2023 to 2030. The report further segments the market based on dosage form, service type, and company size.

Market Size & Forecast (2023-2030), By Dosage Form, USD Million

Tablets & Capsules
Softgel
Powder
Others

Market Size & Forecast (2023-2030), By Service Type, USD Million

Product Formulation and Development
Research & Development (R&D)
Manufacturing and Packaging
Regulatory Compliance
Others

Market Size & Forecast (2023-2030), By Company Size, USD Million

Small Companies
Mid-Sized Companies
Large Companies

Top Related Reports:

Global Nutraceuticals Market: https://meditechinsights.com/global-nutraceuticals-market/

Clinical Nutrition Market: https://meditechinsights.com/global-clinical-nutrition-market/

Pharmaceutical Excipients Market: https://meditechinsights.com/pharmaceutical-excipients-market/

Contact:

Ruta Halde
Associate, Medi-Tech Insights
Phone: +32 498 86 80 79
Email: info@meditechinsights.com
Website: https://meditechinsights.com/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

This release was published on openPR.